Successful Treatment of Stable Vitiligo by Low-Density Cultured Autologous Melanocyte Transplantation Combined With Narrowband Ultraviolet B Therapy

    loading  Checking for direct PDF access through Ovid

Abstract

BACKGROUND

Cultured autologous melanocyte transplantation (CMT) is an effective treatment for stable vitiligo, but the current method is time consuming and expensive because of the requirement of a large number of melanocytes.

OBJECTIVE

To assess the clinical effect of low-density CMT combined with narrowband ultraviolet B (NB-UVB) in treating stable vitiligo.

MATERIALS AND METHODS

The authors treated 8 patients with CMT at a low cell density (less than 2.5 × 104 cells/cm2). Among them, 6 patients underwent NB-UVB therapy after CMT.

RESULTS

All the 6 patients treated with low-density CMT combined with NB-UVB obtained more than 90% repigmentation at the 1-year follow-up.

CONCLUSION

The authors' data suggest that low-density CMT combined with NB-UVB can be an effective form of surgical treatment for stable vitiligo.

Related Topics

    loading  Loading Related Articles